Improved Clinical Outcomes for Heart Transplant Recipients Announced from International Study on Paragonix SherpaPak® CTS

CAMBRIDGE, MASSACHUSETTS, April 28, 2021 - Paragonix Technologies announced the presentation of the First Report of the GUARDIAN Registry1 at the International Society for Heart and Lung Transplantation 2021 Annual Meeting.  The GUARDIAN study is the…

Continue ReadingImproved Clinical Outcomes for Heart Transplant Recipients Announced from International Study on Paragonix SherpaPak® CTS